Earnings Preview For PDS Biotechnology
Portfolio Pulse from Benzinga Insights
PDS Biotechnology (NASDAQ:PDSB) is scheduled to release its quarterly earnings report on March 27, 2024, with analysts expecting an EPS of $-0.44. The company's past earnings performance shows a mix of beats and misses, with the share price reacting accordingly. Shares are currently trading at $4.73, down 18.75% over the last year. Investors will be keenly watching for not just the earnings results but also the company's guidance for future growth.
March 26, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
PDS Biotechnology is expected to report an EPS of $-0.44 for the upcoming quarter. Historical performance shows variability in beating EPS estimates and its impact on stock price. Currently trading at $4.73, down 18.75% over the last year, the earnings report and future guidance will be crucial for investor sentiment.
Given PDS Biotechnology's mixed history of beating EPS estimates and the significant impact of guidance on stock prices, the upcoming earnings report is highly relevant. However, the score is neutral due to the uncertainty surrounding the actual results and guidance, which could either positively or negatively affect the stock price in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100